Skip to main content
. 2016 Feb 22;2016(2):CD006405. doi: 10.1002/14651858.CD006405.pub3

Comparison 1. HFNC versus CPAP for primary respiratory support after birth.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Death or CLD 4 439 Risk Ratio (M‐H, Fixed, 95% CI) 1.66 [0.56, 4.94]
1.1 < 28 weeks 0 0 Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.2 28 ‐ 32 weeks 1 37 Risk Ratio (M‐H, Fixed, 95% CI) 2.55 [0.29, 22.31]
1.3 ≥ 32 weeks 1 88 Risk Ratio (M‐H, Fixed, 95% CI) 6.54 [0.32, 132.33]
1.4 < 37 weeks' (subgroup data not available) 3 314 Risk Ratio (M‐H, Fixed, 95% CI) 0.76 [0.15, 3.77]
2 CLD 4 439 Risk Ratio (M‐H, Fixed, 95% CI) 2.07 [0.64, 6.64]
2.1 < 28 weeks 0 0 Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.2 28 ‐ 32 weeks 1 37 Risk Ratio (M‐H, Fixed, 95% CI) 2.55 [0.29, 22.31]
2.3 > 32 weeks 1 88 Risk Ratio (M‐H, Fixed, 95% CI) 6.54 [0.32, 132.33]
2.4 < 37 weeks' (subgroup data not available) 3 314 Risk Ratio (M‐H, Fixed, 95% CI) 1.06 [0.19, 5.97]
3 Death 4 439 Risk Ratio (M‐H, Fixed, 95% CI) 0.36 [0.01, 8.73]
3.1 < 28 weeks 0 0 Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.2 28 ‐ 32 weeks 1 37 Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.3 > 32 weeks 1 88 Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.4 < 37 weeks' (subgroup data not available) 3 314 Risk Ratio (M‐H, Fixed, 95% CI) 0.36 [0.01, 8.73]
4 Treatment failure within 7 days of trial entry 4 439 Risk Ratio (M‐H, Fixed, 95% CI) 1.30 [0.73, 2.34]
4.1 < 28 weeks 0 0 Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.2 28 ‐ 32 weeks 1 37 Risk Ratio (M‐H, Fixed, 95% CI) 0.17 [0.01, 3.34]
4.3 > 32 weeks 1 88 Risk Ratio (M‐H, Fixed, 95% CI) 1.13 [0.41, 3.08]
4.4 < 37 weeks' (subgroup data not available) 3 314 Risk Ratio (M‐H, Fixed, 95% CI) 1.77 [0.81, 3.89]
5 Intubation within 7 days of trial entry 2 247 Risk Ratio (M‐H, Fixed, 95% CI) 2.38 [0.86, 6.57]
6 Intubation at any time point after trial entry 1 125 Risk Ratio (M‐H, Fixed, 95% CI) 1.16 [0.49, 2.71]
7 Duration of any respiratory support (days) 2 192 Mean Difference (IV, Fixed, 95% CI) 0.97 [0.08, 1.86]
8 Duration of supplemental oxygen (days) 1 125 Mean Difference (IV, Fixed, 95% CI) 3.70 [‐0.66, 8.06]
9 Duration of hospitalisation (days) 3 262 Mean Difference (IV, Fixed, 95% CI) 0.50 [‐0.55, 1.56]
10 Pneumothorax 3 369 Risk Ratio (M‐H, Fixed, 95% CI) 0.54 [0.17, 1.79]
11 Nosocomial sepsis 4 439 Risk Ratio (M‐H, Fixed, 95% CI) 1.29 [0.66, 2.54]
12 Gastrointestinal perforation or severe NEC 1 125 Risk Ratio (M‐H, Fixed, 95% CI) 3.46 [0.14, 83.27]
13 Days to full feeds 2 195 Mean Difference (IV, Fixed, 95% CI) ‐0.41 [‐1.46, 0.63]
14 Nasal trauma 3 258 Risk Ratio (M‐H, Fixed, 95% CI) 0.62 [0.34, 1.15]